This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue.

      

You are about to leave a GSK website

Third party content disclaimers

 

You are about to leave a GSK website. By clicking this link, you will be taken to a website that is independently operated and not managed by GSK. The website you are linking to is not controlled or endorsed by GSK and GSK assumes no responsibility for the content on the website. If you wish to proceed, click "OK". If you do not wish to leave this website, click “CANCEL”.

OK

CANCEL

Welcome to GSK Malaysia

We provide healthcare professionals in Malaysia with relevant information on GSK products and related therapy areas, events and educational content designed to help you support your patients.

Register a free account now

Respiratory

Discover GSK’s 40-year heritage and on-going contribution to respiratory medicine.

Vaccines

Our Vaccines business is one of the largest in the world, developing, producing and distributing over 2 million vaccines every day to people across 170 countries.

Adverse events should be reported to drugsafetyinfo.my@gsk.com

Welcome to GSK Malaysia

We provide healthcare professionals in Malaysia with relevant information on GSK products and related therapy areas, events and educational content designed to help you support your patients

 

HEAD-TO-HEAD DATA VS. ANOTHER ONCE-DAILY LAMA/LABA*

Umeclidinum/vilanterol

*Anoro showed superiority on primary endpoint of trough FEV1 compared to TIO/OLO (p<0.001) [1]

Ref 1: Feldman G.J et al. Adv Ther 2017; 34:doi 10.1007/s12325-017-0626-4

Learn more

Relvar Salford Lung Study (SLS)

Fluticasone furoate/ Vilanterol

SLS is a pioneer trial that reflected daily clinical practice with broad patient population

Learn more

Expert perspectives

Your Online Healthcare Partner

The purpose of this web site is to support Malaysia healthcare professionals in their daily practice. It aims to provide information on GSK prescription products, our resources, latest GSK news and events.

Trade marks are owned by or licensed to the GSK group of companies

Adverse events should be reported to drugsafetyinfo.my@gsk.com